Back to search results

Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ

Abroad (travel likely)RecruitingPHASE3

Conditions

DCIS · Breast Cancer · Breast Neoplasms · Sentinel Lymph Node

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Baylor College Of Medicine, Houston, Texas, United States

    Contact: Study coordinator (Alastair Thompson)

  • The University of Hong Kong-Shenzhen Hospital, Hong Kong, Hong Kong

    Contact: Study coordinator (Ava Kwong)

  • Falun Lasarett, Falun, Dalarna County, Sweden

    Contact: Study coordinator (Gunilla Christenson) · gunilla.christenson@ltdalarna.se

  • Växjö County Hospital, Vaxjo, Kronoberg County, Sweden

    Contact: Study coordinator (Imad Mohamed) · imad.mohammed@ltkronoberg.se

  • Skåne University Hospital, Lund, Skåne County, Sweden

    Contact: Study coordinator (Emma Nimeus) · emma.nimeus@med.lu.se

  • Västmanland County Hospital, Västerås, Västmanland County, Sweden

    Contact: Study coordinator (Staffan Eriksson) · staffan.eriksson@regionvastmanland.se

  • Sahlgrenska University Hospital, Gothenburg, Västra Götaland County, Sweden

    Contact: Study coordinator (Fredrik Wärnberg) · fredrik.warnberg@vgregion.se

  • Uppsala University Hospital, Uppsala, Sweden

    Contact: Study coordinator (Andreas Karakatsanis) · andreas.karakatsanis@uu.se · +46765864826

  • Linköping University Hospital, Linköping, Östra Götaland, Sweden

    Contact: Study coordinator (Guyla Nagy, MD) · guyla.nagy@regionostergotland.se
    Contact: Study coordinator (Eva Vikhe Patil) · eva.vikhe.patil@regionostergotland.se
Study leads

  • Andreas Karakatsanis, PhD

    Principal Investigator

    Uppsala University

View source on ClinicalTrials.gov(opens in a new tab)